worldwide@absin.cn
  • Sign in or Register
    My account Recent orders Wish list Address management

    Sign out

  • Cart 0
    The latest additions

      0 items in total

      Subtotal $0.00

      Go to cart
    • English
      Chinese
    爱必信(absin)官网
    爱必信(absin)官网

    000000 Citations

    Home
    Products
    Resources
    Product ApplicationCalculation ToolsFAQsCitationsElectronic Documents
    About us
    Contact us
    worldwide@absin.cn
    • Sign in or Register
      My account Recent orders Wish list Address management

      Sign out

    • Cart 0
      The latest additions

        0 items in total

        Subtotal $0.00

        Go to cart
      • English
        Chinese
      爱必信(absin)官网
      爱必信(absin)官网

      000000 Citations

      Home
      Products
      Resources
      Product ApplicationCalculation ToolsFAQsCitationsElectronic Documents
      About us
      Contact us
      Home
      abs50013 (43 Citations)

      Absin 5-Color IHC Kit (Anti-Rabbit and Mouse Secondary Antibody) gold_icon

      Multicolor kit
      Product Image
      • Datasheet
      • Collect
      • Share:
        Share This on facebook
        Share This on twitter
        Share This on pinterest
        Share This on linkedin
        Share This on skype
        Share This on telegram
        Share This on whatsapp
        Share This on wechat
      Request bulk quotation
      Add to Cart
      • Product Details
      • FAQ
      • Citations(43)
      • Documents
      Tips : This product is for research use only. Not for use in diagnostic prodcedures.
      Dear customer, if you have any questions or want to know about our products, you can click the "I want to ask" button to fill in your questions. Unsuccessful submission? Please contact worldwide@absin.cn.
      Ask questions
      Tumor-Derived CD109 Orchestrates Reprogramming of Tumor-Associated Macrophages to Dampen Immune Response

      Tianming Cui, Linmao Sun, Xinyu Guo, Cheng Cheng, Ning Zhang, Shuo Zhou, Qi Chu, Changjian Xing, Shuhang Liang, Yufeng Liu, Changyong Ji, Xianying Li, Shengwei Tao, Xuetian Gu, Kun Ma, Chenghui Wu, Junhui Chu, Yumin Fu, Sitao Han, Yuchen Zhang, Jiareng Ye, Yao Liu, Jiabei Wang, Lianxin Liu

      Journal of Hepatology. 2025 Apr 10 .

      Influencing factors:26.800

      Bile acid receptor FXR promotes intestinal epithelial ferroptosis and subsequent ILC3 dysfunction in neonatal necrotizing enterocolitis

      Yuxin Zhang, Yuchao Jing, Juan He, Rui Dong, Tongyang Li, Fang Li, Xiaoqing Zheng, Gaoyu Liu, Ran Jia, Jin Xu, Fan Wu, Chunhong Jia, Jin Song, Lijuan Zhang, Pan Zhou, Haitao Wang, Zhi Yao, Qiang Liu, Ying Yu, Jie Zhou

      Immunity. 2025 Mar 1 .

      Influencing factors:25.500

      Radiogenomic method combining DNA methylation profiles and magnetic resonance imaging radiomics predicts patient prognosis in skull base chordoma

      Xiaoyu Deng, Peiran Li, Kaibing Tian, Fan Zhang, Yumeng Yan, Yanghua Fan, Zhen Wu, Junting Zhang, Jiang Du, Wei Chen, Liang Wang

      Clin Epigenetics. 2025 Feb 17 .

      Influencing factors:4.800

      CircMVP promotes METTL3 activation mediated CTNNB1 m6A modification in the inhibition of colorectal cancer in B7-H3 dependence antitumor immunity

      Fang Wang , Qian Wang , Yongfeng Wu, Zebo Huang, Xincao Zhong, Hunan Wang , Chen Yang , Yan Qin, Xiaowei Qi, Xiaosong Ge , Yong Mao

      Int J Biol Sci. 2025 Jan 1 .

      Influencing factors:8.200

      METTL1 mediates PKM m7G modification to regulate CD155 expression and promote immune evasion in colorectal cancer

      Fang Wang # , Chen Yang # , Fang Zheng #, Yang Yan , Guifang Li , Yanyan Feng, Hejia Xu , Zilong He, Dongyan Cai, Hairong Sun, Xiaowei Qi, Yong Mao

      J Transl Med. 2024 Dec 31 .

      Influencing factors:6.100

      The pan-cancer landscape of aldo-keto reductase1B10 reveals that its expression is diminished in gastric cancer

      Anqi Wu  , Hao Li , Mengnan Gao , Juan Liang, Jiaqi Huang, Jaume Farrés, Deliang Cao, Guoqing Li

      Front Immunol. 2024 Dec 6 .

      Influencing factors:5.700

      Characterisation and Clinical Relevance of Tertiary Lymphoid Structures in Primary Biliary Cholangitis

      Hongyu Chu , Yanni Li , Hui Yang , Yuhang Liu , Rongrong Zheng , Xue Zhang , Xiaoyi Wang , Jingwen Zhao , Yujie Zhang, Quan Wang, Ying Ran , Liping Guo , Simin Zhou , Man Liu , Wenjing Song, Bangmao Wang , Long Li, Lu Zhou

      Liver Int. 2024 Nov 18 .

      Influencing factors:6.000

      乳腺癌微环境中三级淋巴结构评分与类别转换记忆B细胞的相关性及其对患者生存期的影响

      朱良啸;堵一乔;王文惠;蒋光洁;张超;高丰厚

      现代肿瘤医学. 2024 Nov 15 .

      Pan-cancer analysis of STAT3 indicates its potential prognostic value and correlation with immune cell infiltration in prostate cancer

      Zhouting Tuo, Hesong Zhang, Ke He, Zhiwei Jiang, Chao Jiang, Xin Chen, Haichao Yuan

      Discover Oncology. 2024 Nov 14 .

      Influencing factors:2.800

      CILP Inhibits Hyaline Cartilage Fibrosis and Chondrocyte Ferroptosis via Keap1-Nrf2 Axis in Early Osteoarthritis Exercise Therapy

      Shuangshuo Jia, Zhehan Hu, Zihan Li, Weiming Zhang, View ORCID ProfileLiang Chen, Changping Niu, Ziqi Zhao, Yuhan Sun, Gang Yao, Yang Wang, Yue Yang

      biorxiv. 2024 Nov 3 .

      CILP from Cartilage Intermediate Zone Inhibits Hyaline Cartilage Fibrosis and Chondrocyte Ferroptosis via Keap1-Nrf2 Axis in Early Osteoarthritis Exercise Therapy

      Shuangshuo Jia, Zhehan Hu, Zihan Li, Weiming Zhang, Liang Chen, Changping Niu, Ziqi Zhao, Yuhan Sun, Gang Yao, Yang Wang, Yue Yang

      bioRxiv. 2024 Nov 3 .

      Losartan-based nanocomposite hydrogel overcomes chemo-immunotherapy resistance by remodeling tumor mechanical microenvironment

      Xiaodong Hou, Yuting Shen, Bin Huang, Qiuyan Li, Shaoyue Li, Tingting Jiang, Xuexia Shan, Weichen Xu, Shuo Liu, Shengbo Wu, De Zhao, Anqi Zhu, Liping Sun, Huixiong Xu & Wenwen Yue

      Journal of Nanobiotechnology. 2024 Oct 30 .

      Influencing factors:5.294

      Mevalonate kinase inhibits anti-tumor immunity by impairing the tumor cell-intrinsic interferon response in microsatellite instability colorectal cancer

      Yanqiao Zhang, Yuanyu Liao, Rui Yang, Bojun Wang, Yuli Ruan, Luying Cui, Jiani Yang, Xuefan Yu, Shuling Han, Yuanfei Yao, Xindi Luan, Yingjue Li, Mengde Shi, Shuijie Li, Chao Liu

      research square. 2024 Oct 7 .

      RUNX1, FUS, and ELAVL1-induced circPTPN22 promote gastric cancer cell proliferation, migration, and invasion through miR-6788-5p/PAK1 axis-mediated autophagy

      Shuo Ma, Yanhua Xu, Xinyue Qin, Mei Tao, Xinliang Gu, Lei Shen, Yinhao Chen, Ming Zheng, Shiyi Qin, Guoqiu Wu, Shaoqing Ju

      Cell Mol Biol Lett. 2024 Jul 2 ; Cell Mol Biol Lett:-

      Influencing factors:8.300

      RUNX1, FUS, and ELAVL1-induced circPTPN22 promote gastric cancer cell proliferation, migration, and invasion through miR-6788-5p/PAK1 axis-mediated …

      Shuo Ma,Yanhua Xu,Xinyue Qin,Mei Tao,Xinliang Gu,Lei Shen,Yinhao Chen,Ming Zheng,Shiyi Qin,Guoqiu Wu,Shaoqing Ju

      Cell Mol Biol Lett. 2024 Jul 2 .

      Influencing factors:9.200

      ScRNA-seq revealed the tumor microenvironment heterogeneity related to the occurrence and metastasis in upper urinary tract urothelial carcinoma

      Shiyong Xin,Yanwei Zhang,Zhenhua Zhang,Ziyao Li,Xianchao Sun,Xiang Liu,Liang Jin,Weiyi Li,Chaozhi Tang,Wangli Mei,Qiong Cao,Haojie Wang,Zhihao Wei,Zhen Zhou,Rongbing Li,Xiaofei Wen,Guosheng Yang,Weihua Chen,Junhua Zheng,Lin Ye

      Cancer Gene Ther. 2024 Jun 14 .

      Influencing factors:4.800

      EGFR突变肺鳞癌TKIs治疗疗效及耐药机制探索

      陈志鑫

      浙江中医药大学. 2024 May 1 .

      Three-dimensional chromatin analysis reveals Sp1 as a mediator to program and reprogram HPV-host epigenetic architecture in cervical cancer

      Canhui Cao, Qian Xu, Zhixian Zhu, Miaochun Xu, Ye Wei, Shitong Lin, Sheng Cheng, Wenhua Zhi, Ping Hong, Xingyu Huang, Da Lin, Gang Cao, Yifan Meng, Ping Wu, Ting Peng , Juncheng Wei, Wencheng Ding, Xiaoyuan Huang, WingKin Sung, Gang Chen, Peng Wu

      Cancer Letters. 2024 Apr 28 .

      Influencing factors:9.700

      Identification of TAP1 as a T-cell related therapeutic target in gastric cancer by mediating oxalipliatin-related synergistic enhancement of immunotherapy

      Yupeng Zhao, Ziyuan Liu, Kaiyuan Deng, Huiheng Qu, Qing Zhang, Peng Zhou, Mengqi Yang, Xiao Yang, Hao Wang, Ranran Li, Jiazeng Xia

      Int Immunopharmacol. 2024 Apr 8 .

      Influencing factors:4.800

      Targeting SIRT4/TET2 Signaling Alleviates Human Keratinocyte Senescence by Reducing 5-hydroxymethylcytosine Loss

      Yi Yi , Yuchang Wang , Yiping Wu , Yukun Liu

      Laboratory Investigation. 2024 Feb 1 ; 2:-

      Influencing factors:5.000

      Single-cell RNA sequencing reveals pro-invasive cancer-associated fibroblasts in hypopharyngeal squamous cell carcinoma

      Zhimou Cai, Lin Chen, Siyu Chen, Ruihua Fang, Xiaolin Chen, Wenbin Lei

      Cell communication and signaling. 2023 Oct 18 .

      Influencing factors:8.400

      Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer

      He Xing, Peng Yaorong, He Gui, Ye Huilin, Liu Liqiang, Zhou Qixian, Shi Juanyi, Fu Sha, Wang Jie, Zhou Zhenyu, Li Wenbin

      Journal of Translational Medicine. 2023 Oct 12 .

      Influencing factors:7.4

      The diapause-like colorectal cancer cells induced by SMC4 attenuation are characterized by low proliferation and chemotherapy insensitivity

      Xuedan Sun, Lifang He, Hong Liu, Rick Francis Thorne, Taofei Zeng, Liu Liu, Bo Zhang, Miao He, Yabin Huang, Mingyue Li, Enyi Gao, Mengyao Ma, Cheng Cheng, Fanzheng Meng, Chuandong Lang, Hairui Li, Wanxiang Xiong, Shixiang Pan, Delong Ren, Bingyi Dang, Yi Yang, Mian Wu, Lianxin Liu

      Cell Metabolism. 2023 Aug 4 .

      Influencing factors:29

      An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS mutant intrahepatic cholangiocarcinoma

      Mao Zhang, Yingying Huang, Jiaomeng Pan, Chen Sang, Youpei Lin, Liangqing Dong, Xia Shen, Yingcheng Wu, Guohe Song, Shuyi Ji, Fen Liu, Mengcheng Wang, Yuyan Zheng, Sirui Zhang, Zefeng Wang, Jianke Ren, Daming Gao, Jian Zhou, Jia Fan, Wu Wei, Jian Lin, Qiang Gao

      Cancer Discovery. 2023 Jul 24 .

      Influencing factors:28.2

      Jinyinqingre Oral Liquid alleviates LPS-induced acute lung injury by inhibiting the NF-κB/NLRP3/GSDMD pathway

      Shuhui WANG,Pan LEI,Ying FENG,Mingzhu JIANG,Zegan LIU,Ting SHEN,Shinan MA,Libo WANG,Xingrong GUO,Shiming DU

      Chinese Journal of Natural Medicines. 2023 Jul 3 .

      Influencing factors:4.6

      ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer

      Xin Shiyong, Liu Xiang, Li Ziyao, Sun Xianchao, Wang Rong, Zhang Zhenhua, Feng Xinwei, Jin Liang, Li Weiyi, Tang Chaozhi, Mei Wangli, Cao Qiong, Wang Haojie, Zhang Jianguo, Feng Lijin, Ye Lin

      Experimental Hematology & Oncology. 2023 May 23 .

      Influencing factors:8.593

      敲低序列相似家族172成员A抑制肝癌细胞增殖和糖酵解

      刘红; 黄亚彬; 刘连新

      中国生物化学与分子生物学报. 2023 Apr 2 .

      ICOS/ICOSLG and PD-1 Co-Expression is Associated with the Progression of Colorectal Precancerous- Carcinoma Immune Microenvironment

      Yu Zhang, Xue-Li Wang, Jing-Jing Liu, Zhen-Yuan Qian, Zheng-Yang Pan, Ni-Ping Song, Hui-Yan Chen, Wei Zhang, Xin Zhang

      Journal of Inflammation Research. 2023 Mar 7 .

      Influencing factors:4.631

      ICOS/ICOSLG and PD-1 Co-expression is associated with the progression of colorectal precancerous-carcinoma immune microenvironment

      Yu Zhang,Xue-Li Wang,Jing-Jing Liu,Zhen-Yuan Qian,Zheng-Yang Pan,Ni-Ping Song,Hui-Yan Chen,Wei Zhang,Xin Zhang

      J Inflamm Res. 2023 Mar 7 .

      Influencing factors:4.200

      Increased NKG2A+CD8+ T-cell exhaustion in patients with adenomyosis

      Wei Liu, Shuman Sheng, Chendi Zhu, Changzhong Li, Yonghui Zou, Chunrun Yang, Zi-Jiang Chen, Fei Wang, Xue Jiao

      Mucosal Immunology. 2023 Feb 23 .

      Influencing factors:8.701

      Increased NKG2A+ CD8+ T-cell exhaustion in patients with adenomyosis

      Wei Liu,Shuman Sheng,Chendi Zhu,Changzhong Li,Yonghui Zou,Chunrun Yang,Zi-Jiang Chen,Fei Wang,Xue Jiao

      Mucosal Immunol. 2023 Feb 23 .

      Influencing factors:7.900

      Extracellular Vesicle–Packaged circATP2B4 Mediates M2 Macrophage Polarization via miR-532-3p/SREBF1 Axis to Promote Epithelial Ovarian Cancer Metastasis

      Wang Fang, Niu Yuequn, Chen Kelie, Yuan Xiaoyu, Qin Yuheng, Zheng Fang, Cui Zhenyan, Lu Weiguo, Wu Yihua, Xia Dajing

      Cancer Immunology Research. 2023 Feb 3 .

      Influencing factors:12.02

      Plasma-derived exosomes contributes to Endothelial-to-mesenchymal transition in moyamoya disease

      Jilan Liu, Chao Chen, Xianyun Qin, Yan Lu, Bin Zhang, Feng Jin

      Research Square. 2023 Jan 4 .

      Intra-Tumoral Secondary Follicle-like Tertiary Lymphoid Structures Are Associated with a Superior Prognosis of Overall Survival of Perihilar Cholangiocarcinoma

      Fa-Peng Zhang, Ke Zhu, Tai-Feng Zhu, Chao-Qun Liu, Hong-Hua Zhang, Lei-Bo Xu, Gang Xiao, Chao Liu

      Cancers. 2022 Dec 12 .

      Influencing factors:6.575

      A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma

      Zhang, Chao, Shen, Hongru, Yang, Tielong, Li, Ting, Liu, Xinyue, Wang, Jin, Liao, Zhichao, Wei, Junqiang, Lu, Jia, Liu, Haotian, Xiang, Lijie, Yang, Yichen, Yang, Meng, Wang, Duan, Li, Yang, Xing, Ruwei, Teng, Sheng, Zhao, Jun, Yang, Yun, Zhao, Gang, Chen, Kexin, Li, Xiangchun, Yang, Jilong

      Nature Communications. 2022 Nov 25 .

      Influencing factors:17.694

      TRIM22 orchestrates the proliferation of glioblastomas and the benefits of TMZ by coordinating the modification and degradation of RIG-I

      Xiaowei Fei,Xiuquan Wu, Ya-Nan Dou, Kai Sun, Qingdong Guo, Lei Zhang, Sanzhong Li, Jialiang Wei, Yu Huan, Xin He, Zhou Fei

      Molecular Therapy-Oncolytics. 2022 Aug 25 .

      Influencing factors:6.311

      TRIM22 orchestrates the proliferation of GBMs and the benefits of TMZ by coordinating the modification and degradation of RIG-I

      Xiaowei Fei, Xiuquan Wu, Ya-Nan Dou, Kai Sun, Qingdong Guo, Lei Zhang, Sanzhong Li, Jialiang Wei, Yu Huan, Xin He, Zhou Fei

      Molecular Therapy-oncolytics. 2022 Aug 25 .

      Influencing factors:5.700

      Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis

      Xin Guan, Liping Sun, Yuting Shen, Fengshan Jin, Xiaowan Bo, Chunyan Zhu, Xiaoxia Han, Xiaolong Li, Yu Chen, Huixiong Xu, Wenwen Yue

      Nat Commun. 2022 May 20 ; 1:-

      Influencing factors:14.919

      Multi-scale integrative analyses identify THBS2+ cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma

      Haitang Yang, Beibei Sun, Liwen Fan, Wenyan Ma, Ke Xu, Sean R. R. Hall, Zhexin Wang, Ralph A. Schmid, Ren-Wang Peng, Thomas M. Marti, Wen Gao, Jianlin Xu, Weiwei Yang, Feng Yao

      Theranostics. 2022 Mar 28 ; 7:-

      Influencing factors:11.556

      SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer

      Tian-Jiao Li, Kai-Zhou Jin, Hao Li, Long-Yun Ye, Peng-Cheng Li, Bruce Jiang, Xuan Lin, Zhen-Yu Liao, Hui-Ru Zhang, Sai-Meng Shi, Meng-Xiong Lin, Qing-Lin Fei, Zhi-Wen Xiao, Hua-Xiang Xu, Liang Liu, Xian-Jun Yu, Wei-Ding Wu

      Cancer Letters. 2022 Jan 22 .

      Influencing factors:8.679

      雷公藤甲素对急性高眼压大鼠视网膜神经节细胞的保护作用

      汪新芳; 马滕

      中国医药导报. 2021 Jun 25 ; 18:-

      Targeting SIRT4/TET2 signaling alleviates human keratinocyte senescence by reducing 5-hmC loss

      Yi Yi,Yuchang Wang,Yiping Wu,Yukun Liu

      Laboratory Investigation. 2021 Feb 1 ; 2:-

      Neoadjuvant Chemotherapy Combined with Camrelizumab for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Cohort Study

      YY Chen, PP Wang, Y Hu, Y Yuan, YS Yang, HS Shi…

      • The batch number you entered does not exist. Please input the correct batch number information
      • Datasheet product specification
      • Products
      • Resources
      • Product Application
      • Calculation Tools
      • FAQs
      • Citations
      • Electronic Documents
      • About us
      • Company Profile
      • Ordering Tools
      • Customer Support
      • Contact us
      Email: worldwide@absin.cn
      picture invalid picture invalid
      ICP:16001690 Absin Bioscience Inc.All rights reserved.